Examining The Decrease In Symptoms In Patients With Dacryocystorhinostomy Both With And Without Silicon Intubation A Randomized Controlled Trial

Original Article

Abstract

Objective: To determine if dacryocystorhinostomy or silicon intubation is more effective in treating nasolacrimal duct obstruction
Study Design: A Randomized Controlled Trial Study
Place and duration of study: This research was conducted over a six-month period, from October 9, 2021, to April 9, 2022, at the Department of Clinical Ophthalmology, Khyber Girls’ Medical College, Hayatabad Medical Complex (HMC), Peshawar.
Materials and Methods: The study comprised 446 patients with nasolacrimal duct blockage (NLDO). Each patient was split up into two cohorts. Group A had cryocystorhinostomy (DCR) with silicon intubation, whereas Group B underwent DCR without intubation.
Results: The average age of the sample was 35.1 + 9.2 years. The mean age of Group B was 35.2 + 9.1 years, whereas the mean age of Group A was 34.9 + 9.3 years (p 0.730). Group A consisted of 61.9% males and group B had 56.5% males (p 0.248). The average number of days that symptoms persisted was 11 + 3.2 days in group A and 10.4 + 2.9 days in group B (p 0.082). As determined by the overall remission of symptoms, group A’s efficacy was 79.4% at follow-up, whereas group B’s was 69.5% (p 0.017).

Conclusion: For those with NLDO, silicon intubation significantly boosts the efficacy of DCR when compared to DCR without intubation.

KeyWords: Nasolacrimal duct obstruction, dacryocystorhinostomy, intubation, silicon, and efficacy.